CADAS138 stands out as a novel therapeutic target in the realm of neurodegenerative diseases. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to reduce disease progression. https://tomasyvif565215.aboutyoublog.com/50368443/a-potential-therapeutic-strategy